Stay updated on Oral Etrasimod in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.

Latest updates to the Oral Etrasimod in Crohn's Disease Clinical Trial page
- Check2 days agoChange DetectedVersion 69 (Revision: v3.5.4) was added, introducing several new sections to the record history such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Study Design, Study Status, and Study Identification; the latest entry also shows Returned: 2026-05-12 and indicates that the Quality Control Review Has Not Concluded.SummaryDifference0.8%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe history section gains an entry for Revision: v3.5.3, replacing the previous v3.5.2. This reflects a new recorded update to the page.SummaryDifference0.0%

- Check23 days agoChange DetectedThe record’s status was updated to indicate that results have been submitted. Previously, the study showed no results posted.SummaryDifference0.0%

- Check31 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the record history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page shows a new revision label v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Oral Etrasimod in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.